nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—VEGFA—glaucoma	0.357	0.509	CbGaD
Minocycline—MMP9—glaucoma	0.346	0.492	CbGaD
Minocycline—SLC22A6—Methazolamide—glaucoma	0.0299	0.556	CbGbCtD
Minocycline—SLC22A6—Acetazolamide—glaucoma	0.0239	0.444	CbGbCtD
Minocycline—MMP9—cornea—glaucoma	0.0142	0.23	CbGeAlD
Minocycline—CASP3—endothelium—glaucoma	0.00535	0.0867	CbGeAlD
Minocycline—SLC22A8—optic choroid—glaucoma	0.00465	0.0753	CbGeAlD
Minocycline—IL1B—endothelium—glaucoma	0.00428	0.0693	CbGeAlD
Minocycline—MMP9—endothelium—glaucoma	0.00356	0.0577	CbGeAlD
Minocycline—VEGFA—Timolol—Levobunolol—glaucoma	0.00315	0.65	CbGdCrCtD
Minocycline—CASP1—connective tissue—glaucoma	0.00307	0.0497	CbGeAlD
Minocycline—CYCS—eye—glaucoma	0.00307	0.0497	CbGeAlD
Minocycline—CYCS—retina—glaucoma	0.00304	0.0492	CbGeAlD
Minocycline—CYCS—connective tissue—glaucoma	0.00295	0.0479	CbGeAlD
Minocycline—CASP3—eye—glaucoma	0.00263	0.0425	CbGeAlD
Minocycline—CASP3—retina—glaucoma	0.0026	0.0422	CbGeAlD
Minocycline—CASP3—connective tissue—glaucoma	0.00253	0.041	CbGeAlD
Minocycline—Doxycycline—MMP1—glaucoma	0.00221	1	CrCbGaD
Minocycline—IL1B—eye—glaucoma	0.0021	0.034	CbGeAlD
Minocycline—IL1B—connective tissue—glaucoma	0.00202	0.0327	CbGeAlD
Minocycline—MMP9—eye—glaucoma	0.00175	0.0283	CbGeAlD
Minocycline—MMP9—connective tissue—glaucoma	0.00168	0.0273	CbGeAlD
Minocycline—ALOX5—connective tissue—glaucoma	0.00133	0.0216	CbGeAlD
Minocycline—SLC22A8—eye—glaucoma	0.000935	0.0151	CbGeAlD
Minocycline—VEGFA—Pindolol—Levobunolol—glaucoma	0.000469	0.0967	CbGdCrCtD
Minocycline—VEGFA—Pindolol—Carteolol—glaucoma	0.000469	0.0967	CbGdCrCtD
Minocycline—VEGFA—Pindolol—Metipranolol—glaucoma	0.000447	0.0922	CbGdCrCtD
Minocycline—VEGFA—Pindolol—Betaxolol—glaucoma	0.000313	0.0645	CbGdCrCtD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL1A—glaucoma	9.54e-05	0.000546	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CCND2—glaucoma	9.52e-05	0.000545	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TP53—glaucoma	9.51e-05	0.000544	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—CDKN1B—glaucoma	9.51e-05	0.000544	CbGpPWpGaD
Minocycline—CASP1—Immune System—TXN—glaucoma	9.44e-05	0.00054	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CTSA—glaucoma	9.38e-05	0.000537	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP2—glaucoma	9.36e-05	0.000535	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TNF—glaucoma	9.34e-05	0.000535	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—TNF—glaucoma	9.34e-05	0.000535	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—glaucoma	9.25e-05	0.000529	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	9.23e-05	0.000528	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—TNF—glaucoma	9.14e-05	0.000523	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TP53—glaucoma	9.1e-05	0.000521	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—BAD—glaucoma	9.08e-05	0.00052	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—NGF—glaucoma	9.01e-05	0.000515	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL1A—glaucoma	8.97e-05	0.000513	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTSA—glaucoma	8.86e-05	0.000507	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CA2—glaucoma	8.86e-05	0.000507	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—NOS3—glaucoma	8.82e-05	0.000505	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—NGF—glaucoma	8.81e-05	0.000504	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—MMP9—glaucoma	8.8e-05	0.000504	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP1—glaucoma	8.78e-05	0.000503	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—NR3C1—glaucoma	8.77e-05	0.000502	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NCK2—glaucoma	8.69e-05	0.000498	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—glaucoma	8.66e-05	0.000496	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—TNF—glaucoma	8.57e-05	0.00049	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	8.5e-05	0.000487	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	8.45e-05	0.000483	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC6A13—glaucoma	8.42e-05	0.000482	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—TP53—glaucoma	8.34e-05	0.000477	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MMP1—glaucoma	8.27e-05	0.000474	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TP53—glaucoma	8.23e-05	0.000471	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TNF—glaucoma	8.17e-05	0.000468	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—TP53—glaucoma	8.12e-05	0.000465	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC4A4—glaucoma	8.03e-05	0.00046	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—FN1—glaucoma	8.01e-05	0.000459	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—SOD1—glaucoma	8e-05	0.000458	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—NOS3—glaucoma	7.9e-05	0.000452	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—glaucoma	7.72e-05	0.000442	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CDKN2A—glaucoma	7.72e-05	0.000442	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—PTGS2—glaucoma	7.7e-05	0.000441	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.64e-05	0.000437	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—TNF—glaucoma	7.61e-05	0.000436	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	7.54e-05	0.000432	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TNF—glaucoma	7.49e-05	0.000428	CbGpPWpGaD
Minocycline—IL1B—Immune System—TXNIP—glaucoma	7.46e-05	0.000427	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—BAD—glaucoma	7.46e-05	0.000427	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—glaucoma	7.46e-05	0.000427	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—NOS3—glaucoma	7.46e-05	0.000427	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—BAD—glaucoma	7.43e-05	0.000425	CbGpPWpGaD
Minocycline—IL1B—Immune System—TBK1—glaucoma	7.32e-05	0.000419	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CDKN1B—glaucoma	7.29e-05	0.000417	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—VEGFA—glaucoma	7.27e-05	0.000416	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—TNF—glaucoma	7.23e-05	0.000414	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	7.23e-05	0.000414	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—glaucoma	7.2e-05	0.000412	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—VEGFA—glaucoma	7.17e-05	0.00041	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	7.14e-05	0.000409	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—C3—glaucoma	7.07e-05	0.000405	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LRP12—glaucoma	7.04e-05	0.000403	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—OPN4—glaucoma	7.03e-05	0.000402	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP9—glaucoma	7.03e-05	0.000402	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—VEGFA—glaucoma	6.99e-05	0.0004	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—glaucoma	6.96e-05	0.000398	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—SOD1—glaucoma	6.94e-05	0.000397	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CDKN1B—glaucoma	6.83e-05	0.000391	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP2—glaucoma	6.8e-05	0.000389	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TNF—glaucoma	6.78e-05	0.000388	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—BCL2L1—glaucoma	6.77e-05	0.000387	CbGpPWpGaD
Minocycline—IL1B—Immune System—C1QB—glaucoma	6.62e-05	0.000379	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CAV1—glaucoma	6.6e-05	0.000378	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—glaucoma	6.6e-05	0.000378	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—glaucoma	6.58e-05	0.000376	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN2B—glaucoma	6.56e-05	0.000376	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—glaucoma	6.56e-05	0.000375	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HEYL—glaucoma	6.54e-05	0.000374	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—PAX6—glaucoma	6.49e-05	0.000371	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.42e-05	0.000368	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—glaucoma	6.41e-05	0.000367	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTGFR—glaucoma	6.33e-05	0.000362	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—VEGFA—glaucoma	6.32e-05	0.000362	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—CDKN1B—glaucoma	6.32e-05	0.000362	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—glaucoma	6.32e-05	0.000361	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—FN1—glaucoma	6.28e-05	0.00036	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL1A—glaucoma	6.26e-05	0.000358	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TXN—glaucoma	6.24e-05	0.000357	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TNF—glaucoma	6.22e-05	0.000356	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—BAD—glaucoma	6.21e-05	0.000355	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	6.18e-05	0.000354	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC6A1—glaucoma	6.16e-05	0.000353	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—BAD—glaucoma	6.13e-05	0.000351	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LRP12—glaucoma	6.11e-05	0.00035	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP1—glaucoma	6.1e-05	0.000349	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—glaucoma	6.02e-05	0.000344	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TNF—glaucoma	5.99e-05	0.000343	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—glaucoma	5.97e-05	0.000342	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CA1—glaucoma	5.97e-05	0.000342	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	5.94e-05	0.00034	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5.94e-05	0.00034	CbGpPWpGaD
Minocycline—IL1B—Immune System—TXN—glaucoma	5.9e-05	0.000338	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CTSA—glaucoma	5.78e-05	0.000331	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—VEGFA—glaucoma	5.68e-05	0.000325	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TNF—glaucoma	5.64e-05	0.000323	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—PAX6—glaucoma	5.63e-05	0.000322	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.59e-05	0.00032	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—FN1—glaucoma	5.57e-05	0.000319	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—FN1—glaucoma	5.56e-05	0.000318	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CA2—glaucoma	5.46e-05	0.000313	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB2—glaucoma	5.44e-05	0.000311	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—glaucoma	5.42e-05	0.00031	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—glaucoma	5.42e-05	0.00031	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.36e-05	0.000307	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.34e-05	0.000305	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.34e-05	0.000305	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—glaucoma	5.31e-05	0.000304	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—glaucoma	5.2e-05	0.000297	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—CDKN1B—glaucoma	5.17e-05	0.000296	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—glaucoma	5.11e-05	0.000292	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP9—glaucoma	5.11e-05	0.000292	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.09e-05	0.000291	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—glaucoma	4.98e-05	0.000285	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RPTOR—glaucoma	4.95e-05	0.000284	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—OPN4—glaucoma	4.88e-05	0.000279	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTT1—glaucoma	4.84e-05	0.000277	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NCK2—glaucoma	4.8e-05	0.000275	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP2—glaucoma	4.72e-05	0.00027	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.7e-05	0.000269	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1A—glaucoma	4.69e-05	0.000268	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—glaucoma	4.58e-05	0.000262	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.55e-05	0.00026	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HEYL—glaucoma	4.54e-05	0.00026	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—glaucoma	4.5e-05	0.000258	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.49e-05	0.000257	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTGFR—glaucoma	4.4e-05	0.000252	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.31e-05	0.000246	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—glaucoma	4.29e-05	0.000246	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CDKN1B—glaucoma	4.27e-05	0.000245	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—OPN4—glaucoma	4.24e-05	0.000243	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SOD1—glaucoma	4.12e-05	0.000236	CbGpPWpGaD
Minocycline—CASP1—Immune System—C3—glaucoma	4.12e-05	0.000236	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HDAC9—glaucoma	4.08e-05	0.000234	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MMP2—glaucoma	4e-05	0.000229	CbGpPWpGaD
Minocycline—CASP1—Immune System—BCL2L1—glaucoma	3.94e-05	0.000226	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HEYL—glaucoma	3.94e-05	0.000225	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.92e-05	0.000225	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ABCA1—glaucoma	3.86e-05	0.000221	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP1B1—glaucoma	3.86e-05	0.000221	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TXN—glaucoma	3.85e-05	0.00022	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTGFR—glaucoma	3.82e-05	0.000218	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN2A—glaucoma	3.75e-05	0.000215	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—glaucoma	3.61e-05	0.000207	CbGpPWpGaD
Minocycline—CASP1—Immune System—BAD—glaucoma	3.57e-05	0.000205	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.51e-05	0.000201	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.48e-05	0.000199	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP2—glaucoma	3.48e-05	0.000199	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RPTOR—glaucoma	3.44e-05	0.000197	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NCK2—glaucoma	3.33e-05	0.000191	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN1B—glaucoma	3.32e-05	0.00019	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—glaucoma	3.27e-05	0.000187	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SMO—glaucoma	3.19e-05	0.000183	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—MMP1—glaucoma	3.14e-05	0.00018	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GSTM1—glaucoma	3.08e-05	0.000176	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.07e-05	0.000176	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—CAV1—glaucoma	3.01e-05	0.000173	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RPTOR—glaucoma	2.99e-05	0.000171	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTT1—glaucoma	2.98e-05	0.000171	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL1A—glaucoma	2.93e-05	0.000168	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NTRK2—glaucoma	2.92e-05	0.000167	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NCK2—glaucoma	2.89e-05	0.000166	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—FN1—glaucoma	2.87e-05	0.000164	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MMP2—glaucoma	2.86e-05	0.000164	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HDAC9—glaucoma	2.83e-05	0.000162	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MTHFR—glaucoma	2.73e-05	0.000156	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.71e-05	0.000155	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—VEGFA—glaucoma	2.7e-05	0.000155	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP9—glaucoma	2.61e-05	0.00015	CbGpPWpGaD
Minocycline—IL1B—Immune System—C3—glaucoma	2.57e-05	0.000147	CbGpPWpGaD
Minocycline—CYCS—Metabolism—APOE—glaucoma	2.54e-05	0.000145	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CAV1—glaucoma	2.51e-05	0.000144	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NGFR—glaucoma	2.51e-05	0.000143	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDKN1B—glaucoma	2.49e-05	0.000142	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP2—glaucoma	2.48e-05	0.000142	CbGpPWpGaD
Minocycline—IL1B—Immune System—BCL2L1—glaucoma	2.46e-05	0.000141	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HDAC9—glaucoma	2.46e-05	0.000141	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.41e-05	0.000138	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NTRK1—glaucoma	2.38e-05	0.000136	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP1B1—glaucoma	2.38e-05	0.000136	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ABCA1—glaucoma	2.38e-05	0.000136	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS3—glaucoma	2.28e-05	0.00013	CbGpPWpGaD
Minocycline—IL1B—Immune System—BAD—glaucoma	2.23e-05	0.000128	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SMO—glaucoma	2.22e-05	0.000127	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDKN2B—glaucoma	2.19e-05	0.000126	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EDN1—glaucoma	2.1e-05	0.00012	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—glaucoma	2.09e-05	0.00012	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NTRK2—glaucoma	2.03e-05	0.000116	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NGF—glaucoma	1.93e-05	0.000111	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—VEGFA—glaucoma	1.93e-05	0.00011	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SMO—glaucoma	1.92e-05	0.00011	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NOS3—glaucoma	1.9e-05	0.000109	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GSTM1—glaucoma	1.9e-05	0.000109	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—glaucoma	1.86e-05	0.000107	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—C3—glaucoma	1.84e-05	0.000105	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NTRK2—glaucoma	1.76e-05	0.000101	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NGFR—glaucoma	1.74e-05	9.95e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—glaucoma	1.74e-05	9.95e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APOE—glaucoma	1.71e-05	9.8e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CAV1—glaucoma	1.7e-05	9.71e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTHFR—glaucoma	1.68e-05	9.61e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—glaucoma	1.65e-05	9.46e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NTRK1—glaucoma	1.65e-05	9.46e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FN1—glaucoma	1.61e-05	9.24e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—BAD—glaucoma	1.6e-05	9.13e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOE—glaucoma	1.56e-05	8.95e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDKN1B—glaucoma	1.56e-05	8.9e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CAV1—glaucoma	1.55e-05	8.87e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDKN2B—glaucoma	1.52e-05	8.72e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NGFR—glaucoma	1.51e-05	8.64e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EDN1—glaucoma	1.46e-05	8.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—glaucoma	1.43e-05	8.21e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NTRK1—glaucoma	1.43e-05	8.21e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NGF—glaucoma	1.34e-05	7.69e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDKN2B—glaucoma	1.32e-05	7.57e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOS3—glaucoma	1.28e-05	7.34e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—C3—glaucoma	1.28e-05	7.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EDN1—glaucoma	1.27e-05	7.26e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—glaucoma	1.24e-05	7.1e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOE—glaucoma	1.19e-05	6.8e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CAV1—glaucoma	1.18e-05	6.74e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NOS3—glaucoma	1.17e-05	6.7e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NGF—glaucoma	1.17e-05	6.67e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FN1—glaucoma	1.12e-05	6.41e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDKN1B—glaucoma	1.11e-05	6.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—C3—glaucoma	1.11e-05	6.34e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—BAD—glaucoma	1.11e-05	6.34e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—glaucoma	1.07e-05	6.13e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOE—glaucoma	1.03e-05	5.9e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—glaucoma	1.03e-05	5.89e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CAV1—glaucoma	1.02e-05	5.85e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FN1—glaucoma	9.73e-06	5.57e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—BAD—glaucoma	9.61e-06	5.5e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFA—glaucoma	9.24e-06	5.29e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOS3—glaucoma	8.9e-06	5.1e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOS3—glaucoma	7.73e-06	4.42e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDKN1B—glaucoma	7.71e-06	4.41e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—glaucoma	6.98e-06	4e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDKN1B—glaucoma	6.7e-06	3.83e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFA—glaucoma	6.41e-06	3.67e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—glaucoma	6.2e-06	3.55e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—glaucoma	4.85e-06	2.77e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—glaucoma	4.21e-06	2.41e-05	CbGpPWpGaD
